<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss'><id>tag:blogger.com,1999:blog-2773548673339652373</id><updated>2009-05-15T14:46:07.545-07:00</updated><title type='text'>B. McLaughlin Associates,  Inc. -  BMA - Clinical Research Organization (CRO)</title><subtitle type='html'>Clinical Research Organization (CRO). A Specialized provider of clinical research services to the pharmaceutical, biotechnology and medical device industries. Study Management - Data Management - Regulatory Document Collection - Project Management</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>17</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-7875572234323396186</id><published>2009-05-15T14:28:00.000-07:00</published><updated>2009-05-15T14:46:07.557-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='ASCO'/><category scheme='http://www.blogger.com/atom/ns#' term='American Society of Clinical Oncology'/><title type='text'>American Society of Clinical Oncology - ASCO 2009</title><content type='html'>&lt;strong&gt;&lt;/strong&gt;B. McLaughlin Associates, Inc. will be an exhibitor or attending the following upcoming events. We look forward to seeing you there!&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;ASCO 2009 &lt;/strong&gt;&lt;br /&gt;       Date:                  May 28th – June 2nd, 2009&lt;br /&gt;   Location:    Orlando, FL&lt;br /&gt;   Booth:       2184&lt;br /&gt;   Info:                    &lt;a href="http://www.asco.org/" target="_blank"&gt;Website&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_vZK-xQjSibU/Sg3gVGVi24I/AAAAAAAAACg/yAyo5HuJ9Hw/s1600-h/Asco2009.png"&gt;&lt;img style="cursor: pointer; width: 400px; height: 269px;" src="http://2.bp.blogspot.com/_vZK-xQjSibU/Sg3gVGVi24I/AAAAAAAAACg/yAyo5HuJ9Hw/s400/Asco2009.png" alt="" id="BLOGGER_PHOTO_ID_5336167786586758018" border="0" /&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-7875572234323396186?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/7875572234323396186/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=7875572234323396186' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/7875572234323396186'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/7875572234323396186'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2009/05/asco-2009.html' title='American Society of Clinical Oncology - ASCO 2009'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/_vZK-xQjSibU/Sg3gVGVi24I/AAAAAAAAACg/yAyo5HuJ9Hw/s72-c/Asco2009.png' height='72' width='72'/><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-2501993441957957885</id><published>2009-04-19T22:55:00.000-07:00</published><updated>2009-04-19T22:58:48.951-07:00</updated><title type='text'>Parnership with CROs 2009 Booth 202</title><content type='html'>B. McLaughlin Associates, Inc. will be an exhibitor or attending the following upcoming events. We look forward to seeing you there!&lt;br /&gt;           &lt;br /&gt;             &lt;strong&gt;18th Annual Partnerships with CROs&lt;/strong&gt;&lt;br /&gt;               Date:                  April 28th – 30th, 2009&lt;br /&gt;           Location:    Orlando, FL&lt;br /&gt;           Booth:       202&lt;br /&gt;           Info:                    &lt;a href="http://www.iirusa.com/cropartners/welcome-to-CROs.xml" target="_blank"&gt;Website&lt;/a&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://4.bp.blogspot.com/_vZK-xQjSibU/SewOgMA9ePI/AAAAAAAAACA/AIG1cG02S9M/s1600-h/BMAPartnershipwithCROs2009-1.png"&gt;&lt;img style="margin: 0px auto 10px; display: block; text-align: center; cursor: pointer; width: 400px; height: 269px;" src="http://4.bp.blogspot.com/_vZK-xQjSibU/SewOgMA9ePI/AAAAAAAAACA/AIG1cG02S9M/s400/BMAPartnershipwithCROs2009-1.png" alt="" id="BLOGGER_PHOTO_ID_5326648405416311026" border="0" /&gt;&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-2501993441957957885?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/2501993441957957885/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=2501993441957957885' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/2501993441957957885'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/2501993441957957885'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2009/04/parnership-with-cros-2009-booth-202.html' title='Parnership with CROs 2009 Booth 202'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/_vZK-xQjSibU/SewOgMA9ePI/AAAAAAAAACA/AIG1cG02S9M/s72-c/BMAPartnershipwithCROs2009-1.png' height='72' width='72'/><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-8859106538152800430</id><published>2009-02-22T16:07:00.000-08:00</published><updated>2009-02-22T16:09:52.778-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Pharma'/><category scheme='http://www.blogger.com/atom/ns#' term='Pharmaceuticals'/><category scheme='http://www.blogger.com/atom/ns#' term='CROs'/><category scheme='http://www.blogger.com/atom/ns#' term='Clinical Research Organization - CRO'/><category scheme='http://www.blogger.com/atom/ns#' term='Study Management'/><title type='text'>Study Management</title><content type='html'>&lt;h2&gt;YOUR FIRST CHOICE FOR QUALITY,&lt;br /&gt;         COST-EFFECTIVE STUDY MANAGEMENT&lt;/h2&gt;            &lt;p&gt;&lt;img src="http://www.bmclaughlin.com/images/images_data_sheet/BMADS7.jpg" class="imagespace" align="left" height="131" width="241" /&gt;&lt;/p&gt;           &lt;p&gt;&lt;em&gt;Our team has the experience and industry knowledge required for successful study management.&lt;/em&gt; &lt;/p&gt;           &lt;p&gt; &lt;/p&gt;           &lt;p&gt; &lt;/p&gt;           &lt;p&gt; &lt;/p&gt;           &lt;p&gt;BMA can help you meet your corporate and product development goals by supporting many aspects of your clinical trials. We allow you to focus on other critical functions, effectively getting more out of your internal resources. &lt;/p&gt;           &lt;p style="color: rgb(51, 51, 255); font-weight: bold;" class="quotesDS" align="center"&gt;"Get the most out of your study and resources by partnering with BMA"&lt;/p&gt;           &lt;p&gt;Our goal is to provide world class support services that keep your projects on time, within budget and compliant to all regulatory authorities.&lt;/p&gt;           &lt;ul&gt;&lt;li class="style4"&gt;In-House CRA Responsibilities&lt;/li&gt;&lt;ul&gt;&lt;li class="style4"&gt;Feasibility &amp;amp; Site Selection Activities&lt;/li&gt;&lt;li class="style4"&gt;Creation, Collection &amp;amp; Review of Regulatory Documentation&lt;/li&gt;&lt;li class="style4"&gt;Negotiation of Contracts &amp;amp; Patient Budgets&lt;/li&gt;&lt;li class="style4"&gt;Maintenance of Sponsor Systems &amp;amp; Databases&lt;/li&gt;&lt;li class="style4"&gt;Drug &amp;amp; Biologics Temperature Monitoring  Study Closure Activities&lt;/li&gt;&lt;li class="style4"&gt;Regulatory Document Audit &amp;amp; FDA &lt;/li&gt;&lt;li class="style4"&gt;Submission Support&lt;/li&gt;&lt;li class="style4"&gt;Site Consultation &amp;amp; Support&lt;/li&gt;&lt;li class="style4"&gt;Safety Information &amp;amp; Correspondence Distribution&lt;/li&gt;&lt;li class="style4"&gt;Patient Tracking &amp;amp; Post-Study Follow-Up Provides Support to Field Monitors&lt;/li&gt;&lt;/ul&gt;&lt;li class="style4"&gt;Clinical Study Manager Responsibilities &lt;/li&gt;&lt;ul&gt;&lt;li class="style4"&gt;Study Budget Creation, Review &amp;amp; Maintenance&lt;/li&gt;&lt;li class="style4"&gt;Informed Consent Creation, Review &amp;amp; Maintenance&lt;/li&gt;&lt;li class="style4"&gt;Investigator &amp;amp; CRA Meetings&lt;/li&gt;&lt;li class="style4"&gt;Study Team Management&lt;/li&gt;&lt;li class="style4"&gt;Recruitment &amp;amp; Enrollment Tracking&lt;/li&gt;&lt;li class="style4"&gt;Investigator Site &amp;amp; IP Management&lt;/li&gt;&lt;li class="style4"&gt;Study Timeline Planning &amp;amp; Adherence&lt;/li&gt;&lt;li class="style4"&gt;Provides Direction to Field Monitors&lt;/li&gt;&lt;/ul&gt;&lt;/ul&gt;           &lt;p style="font-weight: bold; color: rgb(51, 51, 255);" align="center"&gt;&lt;span class="quotesDS"&gt;"Your Needs, Our Solution"&lt;/span&gt;&lt;/p&gt;&lt;p style="font-weight: bold; color: rgb(51, 51, 255); text-align: left;"&gt;&lt;a href="http://www.bmclaughlin.com/Study_Management.html"&gt;&lt;span style="color: rgb(0, 0, 0); font-weight: normal;"&gt;http://www.bmclaughlin.com/Study_Management.html&lt;/span&gt;&lt;/a&gt;&lt;br /&gt;&lt;span class="quotesDS"&gt;&lt;/span&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-8859106538152800430?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/8859106538152800430/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=8859106538152800430' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/8859106538152800430'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/8859106538152800430'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2009/02/study-management.html' title='Study Management'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-5111675218916882765</id><published>2009-02-22T16:01:00.000-08:00</published><updated>2009-02-22T16:06:43.829-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Pharmaceutical'/><category scheme='http://www.blogger.com/atom/ns#' term='Pharma'/><category scheme='http://www.blogger.com/atom/ns#' term='Data Management'/><category scheme='http://www.blogger.com/atom/ns#' term='Clinical Monitoring'/><category scheme='http://www.blogger.com/atom/ns#' term='18th Annual Partnerships with CROs'/><title type='text'>Data Management</title><content type='html'>&lt;h2&gt;YOUR FIRST CHOICE FOR QUALITY,&lt;br /&gt;      COST-EFFECTIVE GLOBAL DATA MANAGEMENT SUPPORT&lt;/h2&gt;           &lt;p&gt;&lt;img src="http://www.bmclaughlin.com/images/images_data_sheet/BMADS5.jpg" class="imagespace" align="left" height="131" width="241" /&gt;&lt;em&gt;Timely receipt of accurate clinical data is a necessity. BMA has over 15 years of experience in Data Management.&lt;/em&gt; &lt;/p&gt;           &lt;p&gt; &lt;/p&gt;           &lt;p&gt; &lt;/p&gt;           &lt;p&gt;Accurate and complete data for submission to regulatory agencies around the world is critical for clinical studies. Our staff will work with your investigative sites, field monitors, and the study team to promptly collect and review data for precision throughout the life cycle of your trial.&lt;/p&gt;           &lt;p style="font-weight: bold; color: rgb(51, 51, 255);" class="quotesDS" align="center"&gt;"Get the most out of your study and resources by partnering with BMA"&lt;/p&gt;           &lt;p&gt;Our goal is to provide world class support services that keep your projects on time, within budget and compliant to all regulatory authorities.&lt;/p&gt;           &lt;ul&gt;&lt;li class="style4"&gt;Rapid Data &amp;amp; Query Turnaround&lt;/li&gt;&lt;li class="style4"&gt;Paper &amp;amp; eCRF Expertise&lt;/li&gt;&lt;li class="style4"&gt;Global Support Capabilities&lt;/li&gt;&lt;li class="style4"&gt;Deadline &amp;amp; Rescue Support&lt;/li&gt;&lt;li class="style4"&gt;Data Discrepancy/Query, Dissemination, Collection &amp;amp; Review&lt;/li&gt;&lt;li class="style4"&gt;Data Form Collection &amp;amp; Review&lt;/li&gt;&lt;li class="style4"&gt;eCRF User Support &amp;amp; Site Training&lt;/li&gt;&lt;li class="style4"&gt;Laboratory Normal Range Collection, Transcription &amp;amp; Reconciliation&lt;/li&gt;&lt;li class="style4"&gt;Sponsor &amp;amp; Site Data Entry&lt;/li&gt;&lt;li class="style4"&gt;Patient Tracking &amp;amp; Post-Study Follow-Up &lt;/li&gt;&lt;li class="style4"&gt;Clinical Scientist Support&lt;/li&gt;&lt;ul&gt;&lt;li class="style4"&gt;Patient Profile Review&lt;/li&gt;&lt;li class="style4"&gt;SAE &amp;amp; Narrative Review &amp;amp; Reconciliation&lt;/li&gt;&lt;li class="style4"&gt;Data Point Review&lt;/li&gt;&lt;li class="style4"&gt;Query Generation&lt;/li&gt;&lt;li class="style4"&gt;FDA Submission Support&lt;/li&gt;&lt;/ul&gt;&lt;/ul&gt;&lt;a href="http://www.bmclaughlin.com/Data_Management.html"&gt;http://www.bmclaughlin.com/Data_Management.html&lt;/a&gt;&lt;br /&gt;&lt;h2&gt;&lt;/h2&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-5111675218916882765?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/5111675218916882765/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=5111675218916882765' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/5111675218916882765'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/5111675218916882765'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2009/02/data-management.html' title='Data Management'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-6851585010168876527</id><published>2009-02-22T15:56:00.001-08:00</published><updated>2009-02-22T16:00:31.723-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='18th Annual Partnerships with CROs'/><title type='text'>Upcoming Events</title><content type='html'>B. McLaughlin Associates, Inc. will be an exhibitor or attending the following upcoming events. We look forward to seeing you there!&lt;br /&gt;&lt;br /&gt;&lt;p&gt;              &lt;strong&gt;18th Annual Partnerships with CROs&lt;/strong&gt;&lt;br /&gt;            Date: April 28th – 30th, 2009&lt;br /&gt;        Location:   Orlando, FL&lt;br /&gt;        Booth: 202&lt;br /&gt;        Info: &lt;a href="http://www.bmclaughlin.com/Latest_Information.html"&gt;Website&lt;/a&gt;&lt;/p&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_vZK-xQjSibU/SaHmSoVZDhI/AAAAAAAAAB4/AFJCJ_8ybyo/s1600-h/booth2.jpg"&gt;&lt;img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 327px; height: 400px;" src="http://3.bp.blogspot.com/_vZK-xQjSibU/SaHmSoVZDhI/AAAAAAAAAB4/AFJCJ_8ybyo/s400/booth2.jpg" alt="" id="BLOGGER_PHOTO_ID_5305775043758329362" border="0" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;p&gt;&lt;br /&gt;          &lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;br /&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://www.iirusa.com/cropartners/welcome-to-CROs.xml"&gt;&lt;/a&gt;&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-6851585010168876527?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/6851585010168876527/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=6851585010168876527' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/6851585010168876527'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/6851585010168876527'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2009/02/upcoming-events.html' title='Upcoming Events'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_vZK-xQjSibU/SaHmSoVZDhI/AAAAAAAAAB4/AFJCJ_8ybyo/s72-c/booth2.jpg' height='72' width='72'/><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-8335560388422459016</id><published>2009-02-22T15:50:00.000-08:00</published><updated>2009-02-22T16:07:06.506-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Pharma'/><category scheme='http://www.blogger.com/atom/ns#' term='Pharmaceuticals'/><category scheme='http://www.blogger.com/atom/ns#' term='Clinical Monitoring'/><category scheme='http://www.blogger.com/atom/ns#' term='CROs'/><category scheme='http://www.blogger.com/atom/ns#' term='Clinical Research Organization - CRO'/><title type='text'>Clinical Monitoring</title><content type='html'>&lt;table bgcolor="#ffffff" border="0" cellpadding="0" cellspacing="0" width="100%"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="468"&gt;&lt;h2&gt;&lt;strong class="titlemain"&gt;&lt;/strong&gt;&lt;span class="style3"&gt;YOUR FIRST CHOICE FOR QUALITY, COST-EFFECTIVE ON-SITE MONITORING SERVICES&lt;/span&gt;&lt;/h2&gt;           &lt;p&gt;&lt;img src="http://www.bmclaughlin.com/images/images_data_sheet/BMADS10.jpg" class="imagespace" align="left" height="131" width="241" /&gt;&lt;em&gt;Ensuring that your trial has quality data, is compliant with all applicable regulations, and meets all timelines is a must for success.&lt;/em&gt; &lt;/p&gt;           &lt;p&gt; &lt;/p&gt;           &lt;p&gt; &lt;/p&gt;           &lt;p&gt;Allow BMA field monitors to work with you and your clinical sites to help meet corporate and study timelines by providing monitoring support throughout all phases of a clinical trial. Our professional, industry experienced monitors will support your sites from feasibility through study closeout, as well as assist with audit preparation and submission support. &lt;/p&gt;           &lt;ul&gt;&lt;li class="style4"&gt;On-Site Monitoring Activities&lt;/li&gt;&lt;li class="style4"&gt;Certified Field Monitors&lt;/li&gt;&lt;ul&gt;&lt;li class="style4"&gt;ACRP&lt;/li&gt;&lt;li class="style4"&gt;SoCRA &lt;/li&gt;&lt;/ul&gt;&lt;li class="style4"&gt;Site Feasibility, Qualification &amp;amp; Selection Support &lt;/li&gt;&lt;li class="style4"&gt;Initiation, Interim and Closeout Visits&lt;/li&gt;&lt;li class="style4"&gt;Source Documentation Review &amp;amp; Data Verification&lt;/li&gt;&lt;li class="style4"&gt;Data Discrepancy/Query Support&lt;/li&gt;&lt;li class="style4"&gt;Regulatory Compliance Support &amp;amp; Review&lt;/li&gt;&lt;li class="style4"&gt;IRB Documentation Review&lt;/li&gt;&lt;li class="style4"&gt;Site Preparation for FDA &amp;amp; Sponsor Audits&lt;/li&gt;&lt;li class="style4"&gt;Participation &amp;amp; Presentation at Investigator Meetings&lt;/li&gt;&lt;li class="style4"&gt;Enrollment Review&lt;/li&gt;&lt;li class="style4"&gt;Identification &amp;amp; Addressing of Protocol Deviations &amp;amp; Violations&lt;/li&gt;&lt;li class="style4"&gt;Study Supply Inventory&lt;/li&gt;&lt;li class="style4"&gt;Reporting of Adverse Events &amp;amp; Serious Adverse Events&lt;/li&gt;&lt;/ul&gt;                      &lt;p&gt; &lt;/p&gt;&lt;/td&gt;&lt;td width="11"&gt;&lt;br /&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;a href="http://www.bmclaughlin.com/Clinical_Monitoring.html"&gt;http://www.bmclaughlin.com/Clinical_Monitoring.html&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-8335560388422459016?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/8335560388422459016/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=8335560388422459016' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/8335560388422459016'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/8335560388422459016'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2009/02/clinical-monitoring.html' title='Clinical Monitoring'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-1661775228895057117</id><published>2008-02-15T11:38:00.000-08:00</published><updated>2008-08-11T10:17:40.139-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='BMA is not a staffing firm or just another service provider. We are so much more than that.'/><title type='text'>A Helping Hand In Clinical Research</title><content type='html'>&lt;span style="font-weight:bold;"&gt;B. McLaughlin Associates, Inc.&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;A Helping Hand In Clinical Research&lt;br /&gt;&lt;br /&gt;BMA is a niche provider of clinical research services based in West Chester, Pennsylvania and Phoenix, Arizona. Our services focus on Study Management, Regulatory and Financial Document Retrieval, Clinical Study Agreement/Per Patient Budget Negotiation, Informed Consent Review and Approval, Data Discrepancy Retrieval, and Regulatory Document Audits.&lt;br /&gt;&lt;br /&gt;BMA is a highly customizable team and our services can be modified quickly to help you achieve your goals. We have the capabilities and knowledge to expand our service based upon your needs. &lt;br /&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Why Choose B. McLaughlin Associates, Inc.?&lt;/span&gt;&lt;br /&gt;&lt;br /&gt;Being a CRO in the pharmaceutical industry for the past 15 years, B. McLaughlin Associates, Inc. recognizes that you have many options for your sourcing needs. BMA is not a staffing firm or just another service provider. We are so much more than that. So, why choose BMA? We can address this simply by defining our company structure and philosophy. Structurally, we are a small, cross-functional, niche service provider with expertise specializing in Study Management and Data Management. We seek to employ only experienced, highly professional personnel, as we feel that clients should not sacrifice quality in order to meet their outsourcing needs.&lt;br /&gt;&lt;br /&gt;As a niche services company, we are able to remain nimble to the fluctuating needs of our clients and truly strive to raise the bar on the quality of service provided by a CRO. At BMA, we are very aware that developing a drug is a long, very costly process. By recognizing the cost-value benefit to clients, our philosophy is to develop a strategic partnership with the intent to fulfill more than just a short-term need, but rather to provide a long-term sourcing solution. We truly believe in acting as a partner with our clients and routinely provide a dedicated, specialized team that can lend knowledge, experience, expertise and consistency to our clients’ studies, internal teams and clinical sites. We make every effort to work with you, not simply for you and will familiarize ourselves with your internal processes and unite them with our own, creating a cohesive, dynamic work team.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.bmclaughlin.com"&gt;B. McLaughlin Associates, Inc.&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-1661775228895057117?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/1661775228895057117/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=1661775228895057117' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/1661775228895057117'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/1661775228895057117'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2008/02/helping-hand-in-clinical-research.html' title='A Helping Hand In Clinical Research'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-7371584385275803559</id><published>2008-01-20T08:54:00.001-08:00</published><updated>2008-02-20T09:39:08.488-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Clinical Research Organization - CRO'/><title type='text'>New Domains - Subdomains</title><content type='html'>Domains&lt;br /&gt;&lt;a href="http://www.regulatorybma.com"&gt;www.regulatorybma.com&lt;/a&gt;&lt;br /&gt;&lt;a href="http://www.bmaeast.com"&gt;www.bmaeast.com&lt;/a&gt;&lt;br /&gt;&lt;a href="http://www.bmawest.com"&gt;www.bmawest.com&lt;/a&gt;&lt;br /&gt;&lt;a href="http://www.bmclaughlinassociates.com"&gt;www.bmclaughlinassociates.com&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Subdomains&lt;br /&gt;&lt;a href="http://www.researchservices.bmawest.com"&gt;www.researchservices.bmawest.com&lt;/a&gt;&lt;br /&gt;&lt;a href="http://www.pharmaceuticalservices.bmawest.com"&gt;www.pharmaceuticalservices.bmawest.com&lt;/a&gt;&lt;br /&gt;&lt;a href="http://www.regulatory.bmawest.com"&gt;www.regulatory.bmawest.com&lt;/a&gt;&lt;br /&gt;&lt;a href="http://www.clinicalconsulting.bmawest.com"&gt;www.clinicalconsulting.bmawest.com&lt;/a&gt;&lt;br /&gt;&lt;a href="http://clinicalresearchorganization.bmawest.com"&gt;clinicalresearchorganization.bmawest.com&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-7371584385275803559?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/7371584385275803559/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=7371584385275803559' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/7371584385275803559'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/7371584385275803559'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2008/01/new-domains-subdomains.html' title='New Domains - Subdomains'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-3797351701677010167</id><published>2007-06-01T14:23:00.000-07:00</published><updated>2007-08-14T14:26:12.734-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Inc. East'/><category scheme='http://www.blogger.com/atom/ns#' term='B. McLaughlin Associates'/><title type='text'>BMA -  B. McLaughlin Associates, Inc. East</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://1.bp.blogspot.com/_vZK-xQjSibU/RsId03K9MgI/AAAAAAAAAAM/5lDuWleIxzo/s1600-h/bmaPa.jpg"&gt;&lt;img style="display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;" src="http://1.bp.blogspot.com/_vZK-xQjSibU/RsId03K9MgI/AAAAAAAAAAM/5lDuWleIxzo/s320/bmaPa.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5098670522137129474" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.bmclaughlin.com"&gt;B. McLaughlin Associates, Inc. East&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Our corporate headquarters are located in West Chester, PA, which is 30 minutes from Philadelphia.&lt;br /&gt;&lt;br /&gt;1540 McDaniel Drive&lt;br /&gt;West Chester, PA 19380&lt;br /&gt;Tel: (610) 430-1847&lt;br /&gt;Fax: (610) 430-1970&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-3797351701677010167?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/3797351701677010167/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=3797351701677010167' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/3797351701677010167'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/3797351701677010167'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2007/06/bma-b-mclaughlin-associates-inc-east.html' title='BMA -  B. McLaughlin Associates, Inc. East'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_vZK-xQjSibU/RsId03K9MgI/AAAAAAAAAAM/5lDuWleIxzo/s72-c/bmaPa.jpg' height='72' width='72'/><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-7353829657188381110</id><published>2007-05-14T14:27:00.000-07:00</published><updated>2007-08-14T14:29:36.980-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Inc. Brochure'/><category scheme='http://www.blogger.com/atom/ns#' term='BMA -  B. McLaughlin Associates'/><title type='text'>BMA -  B. McLaughlin Associates, Inc. Brochure</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_vZK-xQjSibU/RsIeWXK9MhI/AAAAAAAAAAU/RM-0fhW6xdk/s1600-h/bmaBrochureSm.jpg"&gt;&lt;img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer;" src="http://3.bp.blogspot.com/_vZK-xQjSibU/RsIeWXK9MhI/AAAAAAAAAAU/RM-0fhW6xdk/s400/bmaBrochureSm.jpg" alt="" id="BLOGGER_PHOTO_ID_5098671097662747154" border="0" /&gt;&lt;/a&gt;&lt;a href="http://www.bmclaughlin.com/marketing/files/WEB_Brochure.pdf"&gt;BMA - B. McLaughlin Brochure&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Please download the latest version of our brochure.&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-7353829657188381110?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/7353829657188381110/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=7353829657188381110' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/7353829657188381110'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/7353829657188381110'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2007/05/bma-b-mclaughlin-associates-inc.html' title='BMA -  B. McLaughlin Associates, Inc. Brochure'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_vZK-xQjSibU/RsIeWXK9MhI/AAAAAAAAAAU/RM-0fhW6xdk/s72-c/bmaBrochureSm.jpg' height='72' width='72'/><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-6752235548511244485</id><published>2006-12-15T10:29:00.000-08:00</published><updated>2008-01-10T09:52:40.258-08:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Clinical Reseach'/><title type='text'>B. McLaughlin Associates, Inc.</title><content type='html'>&lt;a href="http://www.bmclaughlin.com/marketing/BMA_logos_images/BMA_med_silver.gif"&gt;&lt;img style="display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;width: 320px;" src="http://www.bmclaughlin.com/marketing/BMA_logos_images/BMA_med_silver.gif" border="0" alt="" /&gt;&lt;/a&gt;&lt;br /&gt;BMA is a niche provider of clinical research services based in West Chester, Pennsylvania and Phoenix, Arizona. Our services focus on Study Management, Regulatory and Financial Document Retrieval, Clinical Study Agreement/Per Patient Budget Negotiation, Informed Consent Review and Approval, Data Discrepancy Retrieval, and Regulatory Document Audits.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.regulatorybma.com"&gt;www.regulatorybma.com&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-6752235548511244485?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/6752235548511244485/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=6752235548511244485' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/6752235548511244485'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/6752235548511244485'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2006/12/b-mclaughlin-associates-inc.html' title='B. McLaughlin Associates, Inc.'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-3127720279020318029</id><published>2006-08-21T10:57:00.000-07:00</published><updated>2008-08-11T10:15:41.460-07:00</updated><title type='text'>BMA - B. McLaughlin Associates, Inc. West Coast</title><content type='html'>&lt;a href="http://www.bmclaughlin.com/images/bmaphx.jpg"&gt;&lt;img style="display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;width: 320px;" src="http://www.bmclaughlin.com/images/bmaphx.jpg" border="0" alt="" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.bmawest.com"&gt;B. McLaughlin Associates, Inc. West Coast&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;We recently expanded into our Phoenix, AZ office, which opened in August 2005.&lt;br /&gt;&lt;br /&gt;16515 S. 40th Street, Suite 125&lt;br /&gt;Phoenix, AZ 85048&lt;br /&gt;Tel: (480) 659-9120&lt;br /&gt;Fax: (480) 659-9193&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-3127720279020318029?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/3127720279020318029'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/3127720279020318029'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2006/08/b.html' title='BMA - B. McLaughlin Associates, Inc. West Coast'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-2064326771031039187</id><published>2006-07-03T14:13:00.000-07:00</published><updated>2008-08-11T10:19:10.236-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Project Management'/><title type='text'>Project Management</title><content type='html'>Project Management&lt;br /&gt;&lt;br /&gt;BMA will assign the best team member to your project, according to their experience and expertise, and will work together with you to achieve the most accurate and on-time completion of your project. We will work as a cohesive team with your company and, as needed, will expand our capabilities to fit your needs. We pride ourselves on a job well done!&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.bmclaughlin.com/Project_Management.php"&gt;B. McLaughlin Associates, Inc.&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-2064326771031039187?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/2064326771031039187/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=2064326771031039187' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/2064326771031039187'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/2064326771031039187'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2007/08/project-management.html' title='Project Management'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-1646209314337105274</id><published>2006-06-02T14:12:00.000-07:00</published><updated>2007-08-28T14:13:04.069-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Services'/><title type='text'>Additional Services</title><content type='html'>Additional Services&lt;br /&gt;&lt;br /&gt;Our services extend to the following, as well:&lt;br /&gt;&lt;br /&gt;• Global Resource Management&lt;br /&gt;• Contract and Grant Negotiation&lt;br /&gt;• Quality Assurance&lt;br /&gt;• Meeting Planning&lt;br /&gt;• Travel Arrangements and Planning&lt;br /&gt;• Graphic/Web Design&lt;br /&gt;• Large Format Digital Printing&lt;br /&gt;• Signs and Promotional Items&lt;br /&gt;• Document Archiving&lt;br /&gt;• Mailing and shipping&lt;br /&gt;&lt;br /&gt;When you need help, BMA is here to assist you!&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-1646209314337105274?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/1646209314337105274/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=1646209314337105274' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/1646209314337105274'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/1646209314337105274'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2006/06/additional-services.html' title='Additional Services'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-3154252707193213836</id><published>2006-05-02T12:16:00.000-07:00</published><updated>2007-08-22T12:18:21.065-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Mclaughlin'/><title type='text'>Data Management</title><content type='html'>&lt;h1&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;Data Management&lt;/span&gt;&lt;/h1&gt;             &lt;p&gt;&lt;strong&gt;Distribution and Collection of Data Discrepancies&lt;/strong&gt;&lt;/p&gt;             &lt;p&gt;BMA will distribute and collect data discrepancy queries within               an average of 7-14 days from clinical sites in the Americas and               throughout the world. During the life of a clinical trial and,               most importantly, at interim and final deadlines, the timely return               of accurate data is crucial. BMA can help ensure that, through               constant communication with clinical sites and monitors, your clinical               trial is not jeopardized.&lt;/p&gt;             &lt;p&gt;&lt;strong&gt;&lt;br /&gt; Serious Adverse Event Narratives and Reconciliation&lt;/strong&gt;&lt;/p&gt;             &lt;p&gt;Serious Adverse Event retrieval for timely reporting to Regulatory               Authorities, as well as writing SAE Narratives and Reconciliation,               are prepared according to sponsor specifications.&lt;/p&gt;             &lt;p&gt;&lt;br /&gt;             &lt;strong&gt;CRO Interaction and Monitoring&lt;/strong&gt;&lt;/p&gt;             &lt;p&gt;Through our extensive experience with major CROs, metrics for               data management of study data can be developed, as well as monitored               to ensure on-time delivery of clinical data to meet sponsor deadlines.&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-3154252707193213836?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/3154252707193213836/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=3154252707193213836' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/3154252707193213836'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/3154252707193213836'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2007/08/data-management.html' title='Data Management'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-2801238483879390926</id><published>2006-05-02T12:14:00.000-07:00</published><updated>2007-08-22T12:15:31.105-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Inc.'/><category scheme='http://www.blogger.com/atom/ns#' term='BMA - B McLaughlin Associates'/><title type='text'>Clinical Indications</title><content type='html'>&lt;h1&gt;&lt;span style="color:#666666;"&gt;Clinical Indications&lt;/span&gt;&lt;/h1&gt;             &lt;p&gt;&lt;br /&gt;              BMA has worked on clinical trials for the following indications:&lt;br /&gt;             &lt;br /&gt;              Avoidance of Vascular Occlusion&lt;br /&gt;              Arrythmias&lt;br /&gt;              Hypertension&lt;br /&gt;              CHF&lt;br /&gt;              COPD&lt;br /&gt;              Wound Healing&lt;br /&gt;              Diabetes&lt;br /&gt;              Otitis Media&lt;br /&gt;              RSV&lt;br /&gt;              AECB&lt;br /&gt;              Pneumonia (CAP &amp;amp; Nosocomial)&lt;br /&gt;              Pyelonephritis&lt;br /&gt;              UTI&lt;br /&gt;              Sinusitis&lt;br /&gt;              Sinusitis Epidemiology&lt;br /&gt;              Herpes Simplex&lt;br /&gt;              Ovarian Carcinoma&lt;br /&gt;              Kaposi's Sarcoma&lt;br /&gt;              Small Cell Lung Cancer&lt;br /&gt;              Colorectal Cancer&lt;br /&gt;              Acute Myelogenous Leukemia&lt;br /&gt;              Multifocal Leukoencephalopathy&lt;br /&gt;              Lyme DiseasePediatric RLS&lt;br /&gt;              Sepsis&lt;br /&gt;              Breast Cancer&lt;br /&gt;              Coronary Heart Disease&lt;br /&gt;              Thromboembolism&lt;br /&gt;              Thrombocytopenia&lt;br /&gt;              Influenza Vaccine&lt;br /&gt;            HPV Vaccine&lt;/p&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-2801238483879390926?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/2801238483879390926/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=2801238483879390926' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/2801238483879390926'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/2801238483879390926'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2006/05/clinical-indications.html' title='Clinical Indications'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-2773548673339652373.post-8302680210898434251</id><published>2006-05-01T14:32:00.000-07:00</published><updated>2007-08-14T14:36:18.027-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='Inc.  (CRO)'/><category scheme='http://www.blogger.com/atom/ns#' term='BMA -  B. McLaughlin Associates'/><title type='text'>BMA -  B. McLaughlin Associates, Inc.  (CRO)</title><content type='html'>&lt;span style="color: rgb(102, 102, 102);font-size:180%;" &gt;&lt;span style="font-weight: bold;"&gt;Featured Services&lt;/span&gt;&lt;/span&gt;&lt;br /&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;&lt;br /&gt;&lt;span style="font-weight: bold;"&gt;Study Management&lt;/span&gt;&lt;/span&gt;&lt;h1&gt;             &lt;/h1&gt;             &lt;p align="left"&gt;&lt;strong&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;Preparation and Distribution of Study                     Initiation Packets&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;                                          &lt;p&gt;BMA will reproduce and prepare study initiation packets &amp; regulatory                 binders and distribute them to clinical sites. Accurate and on                 time shipments ensure that your clinical trial will meet the best               possible start &lt;strong&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;Collection of Regulatory and Financial Documentation&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;              &lt;p&gt;BMA will work with clinical sites to collect all regulatory and                 financial documentation required for study start-up. We recognize                 that one of the most critical steps of the clinical trial process                 is ensuring that sites are ready for initiation as soon as possible.&lt;br /&gt;                   &lt;br /&gt;   BMA will also collect ongoing documentation throughout the duration of the     clinical trial. This includes, revised 1572s, certification renewals, annual/semi-annual     IRB renewals and all documentation relating to amendments and modifications.     Once documents are collected from clinical sites and reviewed and approved     by BMA, they can be returned to the Sponsor, or filed and retained in our     office until the end of the study. &lt;/p&gt;                              &lt;p&gt; Upon study completion, BMA       will collect       all study close-out documentation, e.g. Finanical Disclosure Forms Part                 B, Notification to IRB of study close-out, etc.&lt;strong&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;Negotiation of Clinical Study Agreements and Per Patient Budgets&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;                                             &lt;p&gt;BMA will produce, distribute and negotiate Sponsor approved Clinical                 Study Agreements and Per Patient Budgets. Using pre-specified guidelines,                 we will work to negotiate the best possible budget on behalf of               the Sponsor.&lt;/p&gt;&lt;p&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;&lt;strong&gt;&lt;br /&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;&lt;strong&gt;Review and Approval of Informed Consent Forms&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;                                            &lt;p&gt;Using FDA and Sponsor specified guidelines, BMA will work with                 clinical sites to ensure that all required Informed Consent Forms                 contain the appropriate language and information. Distribution                 of Study Wide Correspondence&lt;br /&gt;   Throughout the clinical trial, BMA will reproduce and distribute study-wide     correspondence on behalf of the Sponsor.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;&lt;br /&gt;&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;&lt;span style="color: rgb(102, 102, 102);"&gt;Regulatory Document Audits&lt;/span&gt;&lt;/strong&gt;&lt;br /&gt;             &lt;br /&gt;               BMA will review study and investigator files for correct and                     complete content. Once discrepancie&lt;/p&gt;&lt;a href="http://www.bmclaughlin.com/"&gt;www.bmclaughlin.com&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/2773548673339652373-8302680210898434251?l=bmclaughlin.blogspot.com'/&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://bmclaughlin.blogspot.com/feeds/8302680210898434251/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='https://www.blogger.com/comment.g?blogID=2773548673339652373&amp;postID=8302680210898434251' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/8302680210898434251'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2773548673339652373/posts/default/8302680210898434251'/><link rel='alternate' type='text/html' href='http://bmclaughlin.blogspot.com/2006/05/bma-b-mclaughlin-associates-inc-cro.html' title='BMA -  B. McLaughlin Associates, Inc.  (CRO)'/><author><name>B. McLaughlin Associates, Inc.</name><uri>http://www.blogger.com/profile/03807187025540981617</uri><email>noreply@blogger.com</email><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='OpenSocialUserId' value='04544055841218772719'/></author><thr:total xmlns:thr='http://purl.org/syndication/thread/1.0'>0</thr:total></entry></feed>